Edwards Lifesciences (EW) Restructuring Costs (2010 - 2026)

Edwards Lifesciences has reported Restructuring Costs for 15 years, with the latest figure at $37.1 million in Q1 2026.

• For the quarter ending Q1 2026, Restructuring Costs rose 783.33% year-over-year to $37.1 million; the trailing twelve-month figure through Mar 2026 stood at -$62.3 million (down 376.89% YoY), and the FY2025 full-year result was $13.1 million, down 67.57% from the prior year.
• Restructuring Costs for Q1 2026 stood at $37.1 million, up from -$103.7 million in the prior quarter.
• The five-year high for Restructuring Costs was $147.9 million in Q2 2023, with the low at -$103.7 million in Q4 2025.
• Average Restructuring Costs over 5 years is $14.5 million, with a median of $7.1 million recorded in 2022.
• Year-over-year, Restructuring Costs jumped 2324.59% in 2023 and sank 1482.67% in 2025.
• Tracing EW's Restructuring Costs over 5 years: stood at $49.9 million in 2022, then tumbled by 80.16% to $9.9 million in 2023, then dropped by 24.24% to $7.5 million in 2024, then slumped by 1482.67% to -$103.7 million in 2025, then surged by 135.78% to $37.1 million in 2026.
• The last three Restructuring Costs figures came in at $37.1 million (Q1 2026), -$103.7 million (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.

Peer Comparison